Skip to content
HowShorted

DermTech, Inc. short interest in 2022

In 2022, DermTech, Inc.'s disclosed short interest ran from 17.33% of shares outstanding on 14 Jan 2022 to 8.45% on 30 Dec 2022, a change of -8.88 percentage points. The year's high was 21.82% on 29 Apr 2022 and its low 8.45% on 30 Dec 2022, averaging 13.94% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.73 days on 28 Feb 2022. Full history: DermTech, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for DermTech, Inc. in 2022

2022 in figures

Start of year
17.33% (14 Jan 2022)
End of year
8.45% (30 Dec 2022)
Change
-8.88 pp
High
21.82% (29 Apr 2022)
Low
8.45% (30 Dec 2022)
Average
13.94%
Highest days to cover
10.73 (28 Feb 2022)
SEC filings marked
7

Every report in 2022

DermTech, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 202217.33%6.01
31 Jan 202219.03%5.87
15 Feb 202219.79%10.21
28 Feb 202219.30%10.73
15 Mar 202218.80%8.24results (8-K), 10-K filed
31 Mar 202218.63%9.00
14 Apr 202219.60%10.17
29 Apr 202221.82%10.05
13 May 202217.48%3.9310-Q filed, results (8-K)
31 May 202217.28%6.73
15 Jun 202217.69%5.53
30 Jun 202211.30%2.37
15 Jul 202210.38%8.00
29 Jul 202213.40%3.90
15 Aug 20229.43%2.9210-Q filed, results (8-K)
31 Aug 20229.34%7.42
15 Sep 20229.61%8.01
30 Sep 20229.78%6.59
14 Oct 20229.45%7.11
31 Oct 20229.17%7.45
15 Nov 20229.40%2.6510-Q filed
30 Nov 20229.05%5.68
15 Dec 20228.98%7.66
30 Dec 20228.45%5.54

See also: DermTech, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.